Merck has become inexpensive again and combines a good growth outlook with a nice and growing dividend. Learn why MRK stock ...

Pharmaceutical Suspension Global market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033. The Business Research Company's Early Year-End Sa ...

APSA-02 is a biologic commercialized by Armata Pharmaceuticals, with a leading Phase II program in Bacteremia.

Wall Street analysts who follow Viking and Summit expect further gains in 2025. Quick gains are often lost on Wall Street, ...

Lawmakers are looking to break up massive health care conglomerates that manage nearly 80 percent of prescriptions.

India], December 13: Merck Foundation, the philanthropic arm of Merck KGaA Germany, in partnership with the African First Ladies, announced the winners of Merck Foundation's SONG Awards 2023 under two ...

The high-profile tenant is the latest to sign on at the former Merck campus, following Revlon's decision to move its R&D ...

Shares of Merck & Co. Inc. MRK inched 0.74% higher to $102.00 Friday, on what proved to be an all-around mixed trading ...

At least 29 patent suits were filed in the District of New Jersey in November, reflecting a jump from the rate of 18 suits ...

A review found half of the drugs studied had price increases based on new evidence of benefits, while the other half did not.

Chinese biotech firms are emerging in a highly resource-intensive and time-consuming scientific innovation endeavor drug discovery One of the latest ...